NCT00151684View on ClinicalTrials.gov

Diazoxide-Mediated Insulin Suppression in Hyperinsulinemic Obese Men

PHASE2CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

November 30, 2004

Conditions
ObesityHyperinsulinism
Interventions
DRUG

Diazoxide

Trial Locations (1)

Unknown

Rijnstate Hospital, Arnhem

All Listed Sponsors
lead

Rijnstate Hospital

OTHER

NCT00151684 - Diazoxide-Mediated Insulin Suppression in Hyperinsulinemic Obese Men | Biotech Hunter | Biotech Hunter